The event Nucleic Acids and Nanobiosystems in Cancer Theranostics, a meeting for researchers interested in new technologies for cancer treatment, will take place between October 16 and 19, 2024.
The highlighted topics at the meeting are: HPV vaccines with mRNA technology; the use of CAR-T/NK cells for immunotherapy; oncolytic approaches to immunotherapy; ncRNA in theranostics; therapeutic nucleic acid therapies; dynamic platforms for cancer therapy and diagnosis; regulatory aspects of advanced therapies; extracellular vesicles as for nucleic acid nanoparticles.
The event will feature as speakers 24 expert in their fields, both Brazilian and international, as well as sessions for oral presentations and poster presentations.
The event is a partnership between C2PO, Faculdade de Medicina da Universidade de São Paulo (FMUSP), and the Cancer Institute of the State of São Paulo (ICESP), and is supported by the International Centre for Genetic Engineering and Biotechnology (ICGEB) and The São Paulo Research Foundation (FAPESP), along with sponsorship from Cristália, FastBio, Neobio, Promega, Sartorius, Sotelab, and Veritas.
The event will be in a hybrid format, with an in-person component at the ICESP Auditorium and a virtual component. Registration can be done according to the type of participation.